Macrophage inhibitory cytokine-1 as a potential biomarker for racial disparity in prostate cancer

被引：0
|
作者：
Karan, Dev [1 ]
Dubey, Seema [1 ]
Wick, Jo [2 ]
Tawfik, Ossama [2 ]
Sonpavde, Guru [3 ]
VanVeldhuizen, Peter [2 ]
机构：
[1] Univ South Carolina, Sch Med, Columbia, SC USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2016年 / 25卷 / 03期
关键词：
D O I：
10.1158/1538-7755.DISP15-B12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B12
引用
收藏
页数：1
相关论文
共 50 条
  • [1] APPLICABILITY OF MACROPHAGE INHIBITORY CYTOKINEL-1 AS A POTENTIAL BIOMARKER FOR RACIAL DISPARITY IN PROSTATE CANCER
    Dubey, Seema
    Wick, Jo
    Tawfik, Ossama
    Zainfeld, Daniel
    Holzbeierlein, Jeffrey
    Van Veldhuizen, Peter
    Thrasher, Brantley
    Karan, Dev
    JOURNAL OF UROLOGY, 2014, 191 (04): : E503 - E504
  • [2] Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer
    Karan, Dev
    Holzbeierlein, Jeffrey
    Thrasher, J. Brantley
    CANCER RESEARCH, 2009, 69 (01) : 2 - 5
  • [3] Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
    Bauskin, Asne R.
    Brown, David A.
    Kuffner, Tamara
    Johnen, Heiko
    Luo, X. Wei
    Hunter, Mark
    Breit, Samuel N.
    CANCER RESEARCH, 2006, 66 (10) : 4983 - 4986
  • [4] Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype
    Muniyan, Sakthivel
    Pothuraju, Ramesh
    Seshacharyulu, Parthasarathy
    Batra, Surinder K.
    CANCER LETTERS, 2022, 536
  • [5] Use of Macrophage Inhibitory Cytokine-1 as a Biomarker in Screening and Surveillance of Colorectal Neoplasia
    Bortniker, Ethan
    Anderson, Joseph C.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [6] STIMULATION OF MACROPHAGE INHIBITORY CYTOKINE-1 BY PALMITIC ACID ACTIVATES PROSTATE CANCER CELL INVASIVENESS
    Mingguo, Huang
    Narita, Shintaro
    Maita, Shinya
    Numakura, Kazuyuki
    Obara, Takashi
    Inoue, Takamitsu
    Horikawa, Yohei
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2012, 187 (04): : E532 - E532
  • [7] Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases
    Selander, Katri S.
    Brown, David A.
    Sequeiros, Guillermo Blanco
    Hunter, Mark
    Desmond, Renee
    Parpala, Teija
    Risteli, Juha
    Breit, Samuel N.
    Jukkola-Vuorinen, Arja
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (03) : 532 - 537
  • [8] Macrophage Inhibitory Cytokine-1: A review of its pleiotropic actions in cancer
    Khaled, Yazan S.
    Elkord, Eyad
    Ammori, Basil J.
    CANCER BIOMARKERS, 2012, 11 (05) : 183 - 190
  • [9] Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival
    Hayes, Vanessa M.
    Severi, Gianluca
    Southey, Melissa C.
    Padilla, Emma J. D.
    English, Dallas R.
    Hopper, John L.
    Giles, Graham G.
    Sutherland, Robert L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (06) : 1223 - 1225
  • [10] Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer
    Dai, Chunyang
    Zhang, Xiaolei
    Ma, Yanling
    Chen, Zhaowu
    Chen, Shaohua
    Zhang, Yang
    Li, Ming
    BIOMARKERS, 2021, 26 (07) : 598 - 605
12345